Serum amyloid A protein is a clinically useful indicator of acute renal allograft rejection

Nephrology Dialysis Transplantation

Volumn 12, Issue 1, 1997, Pages 161-166

  Hartmann, A ^a   Eide, T C ^a   Fauchald, P ^a   Bentdal, O ^a   Herbert, J ^b   Gallimore, J R ^b   Pepys, M B ^b  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

^b HAMMERSMITH HOSPITAL   (United Kingdom)

Author keywords

Acute phase protein; C reactive protein; Diagnosis; Rejection; Renal transplantation; Serum amyloid a protein

Indexed keywords

ACUTE PHASE PROTEIN; AMYLOID A PROTEIN; AZATHIOPRINE; C REACTIVE PROTEIN; CYCLOSPORIN; IMMUNOSUPPRESSIVE AGENT; PREDNISOLONE; SERUM AMYLOID A;

ADOLESCENT; ADULT; AGED; ARTICLE; EARLY DIAGNOSIS; FEMALE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY ALLOGRAFT REJECTION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

ACUTE DISEASE; ACUTE-PHASE REACTION; ADOLESCENT; ADULT; AGED; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CHILD; FEMALE; GRAFT REJECTION; HUMANS; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; SERUM AMYLOID A PROTEIN; TIME FACTORS;

EID: 0031013963     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/12.1.161     Document Type: Article

References (26)

1. Pepys MB, Baltz ML. Acute phase proteins with special reference to C-reactive protein and related proteins (pentaxins) and serum amyloid A protein. Adv Immunol 1983; 34: 141-212
2. White J, Mëyer E, Hardy MA. Prediction of onset and termination of renal allograft rejection by serum levels of C-reactive protein. Transplant Proc 1981; 13: 682-684
3. Freed B, Walsh A, Pietrocola D et al. Early detection of renal allograft rejection by serial monitoring of serum C-reactive protein. Transplantation 1984; 37: 215-218
4. Groth J, Kaden J, Hoffmann P et al. C-reactive protein and clinical kidney transplantation. Nephron 1984; 37: 236-239
5. Lempert N, Freed B, Godlewski J et al. C-reactive protein: an indicator of rejection episode severity in renal allograft recipients pretreated with donor-specific transfusions. Transplant Proc 1985; 17: 662-664
6. Van Lente F, Castellani W, Abbott LB. Changes in concentrations of C-reactive protein in serum after kidney or heart transplantation. Clin Chem 1986; 32: 633-636
7. Kaden J, Strobelt V, Oesterwitz H et al. Monitoring of renal allograft rejection with fine needle aspiration biopsy and serum C-reactive protein determinations. Transplant Proc 1987; 19: 1657
8. Lempert N, Laffin RJ, Fritzgerald K, Freed BM. Elevation of serum C-reactive protein levels during graft rejection. Transplant Proc 1987; 19: 1683-1685
9. Bruzzone P, Sganga G, Castagneto M, Nanni G, Castiglioni GC. Temporal patterns of C-reactive protein and other acute phase proteins after kidney transplantation. Transplant Proc 1987; 19: 3727-3730
10. Dyck RF. C-reactive protein: a better indicator of complications other than acute rejection in renal allograft recipients? Clin Biochem 1988; 21: 359-362
11. Cohen DJ, Benvenisty AI, Meyer E, Hardy MA. Serum C-reactive protein concentrations in cyclosporine-treated renal allograft recipients. Transplantation 1988; 45: 919-922
12. Lalla MLT, Eklund B, Ahonen J. The clinical significance of serum C-reactive protein after renal transplantation. Transplant Proc 1988; 20: 402-404
13. Fischbach M, Desprez P, Mengus L et al. Evaluation of combination of biologic markers (C-reactive protein, neopterin, and microalbuminuria) in the follow-up of kidney transplantation in children: four years of clinical experience. Transplant Proc 1994; 26: 72-74
14. Maury CP, Teppo A, Eklund B, Ahonen J. Serum amyloid A protein: a sensitive indicator of renal allograft rejection in humans. Transplantation 1983; 36: 501-504
15. Maury CP, Teppo AM, Eklund B, Hayry P, Ahonen J. Serum amyloid A levels in human renal allograft rejection. Clin Sci 1983; 65: 547-550
16. Maury CP, Teppo AM. Comparative study of serum amyloid-related protein SAA, C-reactive protein, and beta 2-microglobulin as markers of renal allograft rejection. Clin Nephrol 1984; 22: 284-292
17. Maury CPJ. Comparative study of serum amyloid A protein and C-reactive protein in disease. Clin Sci 1985; 68: 233-238
18. Maury CP, Teppo AM, Ahonen J. Posttransplantation monitoring of high-density lipoprotein-associated serum amyloid A protein: a new diagnostic aid in the detection of renal allograft rejection. Uremia Invest 1985; 9: 277-280
19. Hocke G, Ebel H, Bittner K et al. A rapid laser immunonephelometric assay for serum amyloid A (SAA) and its application to the diagnosis of kidney allograft rejection. Klin Wochenschr 1989; 67: 447-451
20. Müller T, Schindler S, Sprenger H et al. Prospective analysis of 10 different parameters of acute renal allograft rejection. Transplant Proc 1992; 24: 2731-2734
21. Casl MT, Bulatovic G, Orlic P, Sabljar-Matovinovic M. Serum amyloid A protein monitoring for early prediction of kidney allograft rejection. Nephron 1995; 70: 112-113
22. Cohen DJ, Benvenisty AI, Meyer E et al. Failure of C-reactive protein concentration to rise with acute rejection in cyclosporine-treated renal allograft recipients. Transplant Proc 1986; 18: 713-715
23. Pepys MB. The acute phase response and C-reactive protein. In: Weatherall DJ, Ledingham JGG, Warrell DA, eds. Oxford Textbook of Medicine, 3rd edn., Vol. 2. Oxford University Press, Oxford, 1995; 1527-1533
24. Wilkins J, Gallimore JR, Tennent GA et al. Rapid automated enzyme immunoassay of serum amyloid A. Clin Chem 1994; 40: 1284-1290
25. Shine B, de Beer FC, Pepys MB. Solid phase radioimmunoassays for C-reactive protein. Clin Chim Acta 1981; 117: 13-23
26. Liuzzo G, Biasucci LM, Gallimore JR et al. The prognostic value of C-reactive protein and serum amyloid A protein in severe unstable angina. N Engl J Med 1994; 331: 417-424